Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · Real-Time Price · USD

18.60

+0.60 (3.33%)

At close: Sep 25, 2026, 4:00 PM EDT

18.64

+0.04 (0.22%)

After-hours: Sep 25, 2026, 4:13 PM EDT

Burning Rock Biotech Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	500.64	539.57	515.82	537.44	563.24	507.86
Revenue Growth	-6.65%	4.60%	-4.02%	-4.58%	10.90%	18.13%
Gross Profit	373.23	402.91	362.4	363.23	380.04	364.15
Operating Income	-65.02	-54.85	-322.43	-669.32	-980.41	-797.06
Net Income	-68.03	-55.35	-346.63	-653.69	-971.23	-796.7
Earnings Per Share	-6.42	-5.21	-33.67	-63.84	-93.47	-76.45
EPS Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Central Laboratory Channel	150.04	159.99	175.65	232.81	314.77	319.35
In-Hospital Channel	223.76	224.04	224.49	188.7	175.3	165.12
Pharma Research and Development Channel	126.84	155.54	115.68	115.92	73.17	23.39
Total	500.64	539.57	515.82	537.44	563.24	507.86

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	416.82	480.79	525.99	628.5	907.55	1,497
Total Debt	45.11	43.12	52.32	12.32	50.79	86.69
Net Cash (Debt)	371.71	437.67	473.66	616.18	856.76	1,410
Net Cash Growth	-10.13%	-7.60%	-23.13%	-28.08%	-39.25%	-36.35%
Net Cash Per Share	35.09	41.17	46.02	60.18	82.45	135.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-12.22	-28.44	-92.26	-255.78	-456.81	-477.89
Capital Expenditures	-5.25	-5.25	-5.42	-8.1	-70.29	-210.92
Free Cash Flow	-17.47	-33.69	-97.68	-263.89	-527.1	-688.81
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	74.55%	74.67%	70.26%	67.58%	67.47%	71.70%
Operating Margin	-12.99%	-10.17%	-62.51%	-124.54%	-174.07%	-156.94%
Pretax Margin	-13.27%	-9.97%	-66.06%	-121.19%	-172.08%	-156.70%
Profit Margin	-13.59%	-10.26%	-67.20%	-121.63%	-172.44%	-156.87%
FCF Margin	-3.49%	-6.24%	-18.94%	-49.10%	-93.58%	-135.63%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	2.66	2.81	0.98	1.29	2.90	12.46